In obesity-induced hypertensive rats, telmisartan could also inhibit AT1 receptor-induced oxidative stress in the RVLM and activation of the SNS to a greater extent than losartan, in spite of similar depressor effects (Konno et al., 2012). The gene discussed is AGTR1; the disease is obesity disorder.